HiTech Pharmacal Co News

News on HiTech Pharmacal Co (Ticker: HITK) continually updated from thousands of sources around the net.

Monday Feb 6 | Benzinga

Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating Margin

The trailing-twelve-month operating margin at Hi-Tech Pharmacal Co Inc is 33.13%. HITK's revenue for the same period is $219.97 million.

Comment?

Wed Feb 01, 2012

AmericanBankingNews.com

Hi-Tech Pharmacal (HITK)'s "Buy" Rating Reaffirmed by Canaccord Genuity Analysts

Hi-Tech Pharmacal 's stock had its "buy" rating reaffirmed by research analysts at Canaccord Genuity in a report issued on Wednesday.

Comment?

Tue Jan 31, 2012

BioSpace

Hi-Tech Pharmacal Receives Final Approval for Lorazepam Oral Concentrate

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia AMITYVILLE, N.Y.-- --Hi-Tech Pharmacal Co., Inc.

Comment?

Newsday

LI drugmaker gets OK for anti-anxiety remedy

Newsday 7 day/Optimum Online subscribers click here for full access Not a Newsday or Optimum Online subscriber? Click here Amityville-based Hi-Tech Pharmacal Co.

Comment?

Benzinga

A Peek Into The Market Before The Trading Starts

Pre-open movers US stock futures are higher this morning, ahead of earnings reports from major companies.

Comment?

Theflyonthewall.com

Hi-Tech Pharmacal receives final approval for Lorazepam oral concentrate

Hi-Tech Pharmacal announced that the FDA granted final approval for the Company's Abbreviated New Drug Application for Lorazepam oral concentrate 2mg/mL, the generic for Roxanne’s Lorazepam Intensol® oral concentrate which had combined brand and generic sales of $10 million for the 12 months ended December 2011 according to IMS sales data.

Comment?

Wed Jan 18, 2012

BioSpace

Hi-Tech Pharmacall??'s ECR Pharmaceuticals Subsidiary Launches Hylase?? Wound Gel

Comment?